Quickly verify claims by accessing the underlying experimental data and figures.
Press Enter β΅ to solve
Fuel Your Discoveries
"Science is the systematic classification of experience."
- George Henry Lewes
Quick Explanation
Copied
Core result: Precise editing of the mitochondrial F1Fo-ATP synthase Ξ³-subunit in Trypanosoma brucei identifies a dosage-dependent mechanism where bi-allelic M282F enables complete kDNA loss and triggers major, specific mitochondrial proteome remodeling (pre- vs post-kDNA-loss proteomic signatures).
Evidence is supported by oligo-targeting + drug selection, microscopy, whole-genome sequencing (kDNA + nuclear), and quantitative proteomics with deposited datasets.
Key mechanistic anchor: F1Fo remodeling specifically depletes multiple Fo ATP synthase subunits pre-kDNA-loss, while F1 subunits are largely not depleted, and post-loss depletion centers on kDNA-binding/RNA-processing proteins with increased abundance of mitochondrial import/transport-associated complexes.
Long Explanation
Paper Review (Visual): Origins and consequences of kinetoplast loss in trypanosomes
One-line thesis: A dosage-dependent Ξ³-subunit ATP synthase mutation remodels Fo prior to kDNA loss, and bi-allelic M282F permits complete kinetoplast DNA loss followed by mitochondrial proteome reprogramming.
What this paper contributes
Precision oligo-targeting at the Ξ³ATPase locus and drug-selection enrichment for kDNA-dispensability-associated edits.
Mechanistic split: pre-kDNA-loss proteomics shows highly specific depletion of Fo-associated ATP synthase subunits (not F1), plus post-kDNA-loss depletion of kDNA-binding/RNA-processing proteins and increased transporter/import-related cohorts.
Reproducible assets are described as deposited (ENA PRJNA1380964; PRIDE PXD071938).
2) Dose-response phenotypes: oligomycin vs acriflavine (dosage effect)
The paper reports EC50 shifts relative to wild-type across engineered Ξ³ATPase alleles, emphasizing that acriflavine resistance (kDNA targeting) appears only when M282F is homozygous.
Critical interpretation (skeptical):
Claim supported: M282F displays a recessive behavior with respect to acriflavine resistance in these engineered lines.
Known unknown: The paperβs dose-response readouts are phenotypic; they imply causal coupling between Ξ³ATPase remodeling and kDNA loss propensity, but the mapping from phenotype β molecular bottleneck (e.g., mitochondrial membrane potential threshold, ATPase assembly intermediates, or kDNA maintenance network collapse) is not fully resolved by EC50 alone.
3) Proteomics: ATP synthase remodeling before kDNA loss
Before acriflavine-induced kDNA depletion, the study reports highly specific depletion of all eighteen known nuclear-encoded Fo subunits in homozygous M282F mutants, while F1 component subunits are not depleted (including the mutated Ξ³ subunit).
Counterpoint / caution:
Proteomics coverage caveat: absence of depletion for βF1 subunitsβ depends on detection and quantification depth; the excerpt does not provide per-subunit detection metrics.
4) kDNA loss: verification and fitness cost
The study induces kDNA loss using sublethal acriflavine for 7 days, then selects kDNA-negative clones and verifies complete loss via microscopy and whole-genome sequencing (with kDNA assemblies and minicircle abundance analysis). It reports a growth defect in kDNA-negative clones: doubling time increased by ~47% Β± 24% (n=4) vs parent (6.4 h).
5) Proteomics after kDNA loss: what changes, and how specifically
After acriflavine-induced complete kDNA loss, mitochondrial proteins show selective reductions including kDNA-binding proteins and mitochondrial RNA-processing factors, while several mitochondrial membrane-associated transporters and ER-associated interface cohorts increase in abundance. The paper also reports directionality counts for significantly changed proteins (FDR-based, excerpt: 168 depleted vs 51 increased with stronger depletion).
Skeptical mechanistic take: The post-loss depletion of kDNA-binding and RNA-processing factors is directionally consistent with removal of mitochondrial nucleic acid templates and RNA maturation contexts, but increased abundance of transport/import/interface complexes could also reflect compensatory stress responses, altered organelle biogenesis, or global mitochondrial remodeling programs. The excerpt does not provide causal tests (e.g., whether specific increased complexes are necessary for survival without kDNA).
6) Quality and reproducibility review (what looks strong vs uncertain)
Strengths (evidence quality signals)
Precision genetics at a known locus: The study uses oligo-targeting precision editing at native Ξ³ATPase and validates known alleles (L262P, A273P) while discovering novel aromatic M282F/W/Y variants enriched by oligomycin selection.
Orthogonal confirmation of kDNA state: Microscopy DAPI/MitoTracker plus whole-genome sequencing that specifically shows kDNA class loss without obvious nuclear genome changes.
Proteomics with explicit stats pipeline: The excerpt specifies Orbitrap Astral directDIA + Spectronaut and differential expression using limma with FDR thresholds.
Data availability: ENA and PRIDE IDs are provided in the excerpt.
Remaining uncertainty / blind spots
Selection bias via oligomycin: Choosing survivors under oligomycin enriches for genotypes that tolerate drug pressure; while the study aims to avoid kDNA damage pressure by selecting with oligomycin, this selection could still skew mutational spectra and co-selected backgrounds (e.g., off-target changes). The excerpt does not describe an explicit off-target genome-wide screen beyond targeted locus sequencing in early steps.
Proteomics β mechanism: The core mechanistic picture (remodeled ATP synthase enables kDNA-loss tolerance) is plausible and supported by strong directionality patterns, but causal dissection of which altered cohorts are necessary/sufficient for survival is not shown in the excerpt.
Strain and in vivo generality: The excerpt centers on T. b. brucei Lister 427 bloodstream forms and engineered clones; translation to other strains/life-cycle contexts is not established in the provided text.
7) Mechanistic synthesis (whatβs most evidence-grounded)
ATP synthase remodeling is an early consequence of homozygous Ξ³ATPase M282F.
Pre-kDNA-loss proteomics highlights Fo subunit depletion rather than F1 subunit depletion, consistent with the idea of a remodelled rotary motor state relevant to membrane energetics.
After kDNA loss, mitochondrial proteome remodelling is selective.
kDNA-binding and mitochondrial RNA-processing factors decrease, while transporter/import/interface cohorts increaseβconsistent with both loss of kDNA-linked complexes and compensatory shifts in mitochondrial function/biogenesis.
8) Actionable next steps for a skeptic (what to try next)
Test causality of Fo depletion. If possible, independently perturb Fo assembly components (keeping F1 Ξ³ intact) to see whether similar kDNA-loss tolerance emerges without changing Ξ³ dosage. The excerpt implies assembly-pathway arrest after attachment of F1 to the c-ring, but that model remains interpretive here.
Quantify energetics alongside proteomics. Link membrane potential / ATP synthesis-hydrolysis coupling directly to the proteomic states to reduce ambiguity between βremodelingβ and βenergetic threshold effects.β (The excerpt mentions uncoupling concepts but does not provide a complete causal energetics dataset.)
Check off-target effects using the deposited WGS data. Re-analyze ENA PRJNA1380964 to look for additional genomic variants in kDNA-negative clones that could contribute to adaptation beyond the targeted Ξ³ edit.
Author-review deep dives (bespoke)
Click for targeted author perspectives.
Feedback:
Updated: April 01, 2026
BGPT Paper Review
Study Novelty
80%
The novelty is high because it combines (i) native-locus precision oligo targeting at the Ξ³ATPase locus with (ii) dosage-resolved allele engineering that yields a new M282F/W/Y spectrum and (iii) pre- vs post-kDNA-loss quantitative proteomics to connect ATP synthase remodeling to kinetoplast dispensability, rather than only correlating mutations with phenotypes in natural isolates.
Scientific Quality
80%
Scientific quality is strong due to orthogonal verification (microscopy + kDNA-focused WGS + nuclear stability framing), explicit deposition of sequencing/proteomics data, and quantitative proteomics with stated statistical workflow (limma/FDR). Skeptical weaknesses remain: mechanistic causality for specific proteome cohorts is not fully tested in the excerpt, and selection under oligomycin can introduce genotypic/background bias that would benefit from deeper off-target variant scrutiny.
Study Generality
70%
The findings are biologically specific to T. brucei bloodstream-form engineered Ξ³ATPase alleles and their resulting kDNA dispensability state, though the broader conceptβmitochondrial genome loss tolerance via ATP synthase remodeling and systemic mitochondrial reprogrammingβlikely informs kinetoplastid biology. Generality across strains/life stages is not established in the provided excerpt.
Study Usefulness
90%
High usefulness for researchers: it provides (i) allele-resolved genotypeβphenotype mappings (oligomycin vs acriflavine, hetero vs homo), (ii) proteomic targets and cohorts to probe mechanistically (F_o depletion, kDNA-binding/RNA-processing depletion, transporter/import/interface increases), and (iii) deposited datasets for downstream reanalysis and hypothesis testing.
Study Reproducibility
80%
Reproducibility is supported by clear methods in the excerpt (oligo-targeting workflow, oligomycin/acriflavine dosing schedules, cloning, microscopy staining, proteomics analysis pipeline) and by explicit data deposition IDs. Residual reproducibility uncertainty arises from missing full parameter details for some steps in the excerpt and from dependence on drug selection conditions and clone generation.
Explanatory Depth
80%
The paper goes beyond correlation by engineering the native Ξ³ATPase locus and showing a temporal proteomic sequence (pre-loss F_o remodeling β post-loss kDNA-dependent mitochondrial remodeling), offering a mechanistic scaffold. However, causal links from specific proteome changes to fitness/maintenance outcomes are not fully established in the excerpt, limiting depth to a strong mechanistic model rather than a fully proven pathway.
Ingest ENA PRJNA1380964 and PRIDE PXD071938 to re-call variants and normalize protein abundances across kDNA+ vs kDNAβ clones, generating cohort-level depletion/increase plots and QC coverage summaries.
Get emailed when your analysis is done!
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
Strongman (less likely now): βM282F directly disables acriflavine uptake or DNA damaging specificity without enabling kDNA loss.β Itβs challenged because complete kDNA loss is observed and because proteomics shows systematic depletion of kDNA/RNA-associated cohorts rather than a simple drug-target interaction blockade.
Strongman (less likely now): βHeterozygous M282F should confer acriflavine resistance because oligomycin resistance implies the same mechanism.β This is falsified by the reported EC50 behavior: heterozygous M282F shows only ~1.1-fold acriflavine EC50 shift (non-significant), while homozygous shows ~3-fold and supports complete kDNA loss.
Quick Explanation
Long Explanation
Top Data Sources
ExportMCP
Keep Exploring
Analysis Wizard
Hypothesis Graveyard
Potential Experiments
Discussion
Fuel Your Discoveries
Ask a Follow-Up
Key Insight
